B3 · BRL
PFRM3
Profarma Distribuidora de Produtos Farmaceuticos SA
- Day's range
- R$7.22 – R$7.54
- Day's volume
- R$1.1M
- 52-week range
- R$6.11 – R$9.70
Follow PFRM3 in the Fuolio
See how PFRM3 weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountPFRM3 in numbers
- Market cap
- R$917.5M
- P/E
- 5.93
- P/B
- 0.64
- Dividend yield (12m)
- 8.71%
- Net debt/EBITDA
- 1.85
The 12-month dividend yield of PFRM3 is 8.71%, above its 5-year average of 4.95%.
PFRM3 price history
PFRM3 risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -2.84% | +167.77% | +115.93% |
| Volatility (annualized) | 24.43% | 46.27% | 40.78% |
| Largest drawdown | -25.93% | -25.93% | -43.23% |
| Positive months | 5/12 | 20/36 | 29/60 |
How much did investing in PFRM3 return?
R$1,000.00 invested on 10/01/2021 would be worth R$2,110.81 today.
- Value today in PFRM3
- R$2,110.81
- Return over the period
- +111.08%
- Return per year
- +16.12%
- In the Ibovespa
- R$1,794.02
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
PFRM3 fundamentals
Valuation
- P/E5.93
- P/B0.64
- EV/EBITDA3.22
- EV/EBIT4.73
- EV/Revenue0.17
- P/EBIT2.00
- P/S0.07
- P/OCF1.60
- P/FCF2.39
- Earnings yield21.16%
- PEG ratio0.19
- Earnings per shareR$1.25
- Book value per shareR$11.65
Debt
- Net debtR$1.2B
- Net debt/EBITDA1.85
- Net debt/Equity0.74
- Debt/Equity1.03
- Current ratio1.37
- Quick ratio0.86
- Cash ratio0.12
Efficiency
- Gross margin15.14%
- EBITDA margin5.38%
- Operating margin3.67%
- Net margin1.29%
- Asset turnover1.56
Profitability
- ROE10.71%
- ROA2.02%
- ROIC13.52%
- Payout51.62%
Growth
- Revenue CAGR (5 years)16.22%
- Earnings CAGR (5 years)9.40%
- Revenue growth (year)12.77%
- Earnings growth (year)3.77%
- Revenue growth (quarter)13.20%
- Earnings growth (quarter)30.95%
What is PFRM3's fair price?
Two classic value formulas, with today's numbers. The current price is R$7.40.
- Graham's fair price
- R$18.09
- 144.47% above the price
√(22.50 × R$1.25 × R$11.65)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- R$5.77
- 22.03% below the price
R$0.35 (5-year average) ÷ 6%
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
PFRM3's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 9.51 | 7.01 | 10.73 | 5.62 | 9.12 | 14.43 | 66.88 | -49.99 |
| P/B | 0.69 | 0.51 | 0.49 | 0.30 | 0.48 | 0.53 | 0.80 | 0.48 |
| EV/EBITDA | 3.93 | 2.93 | 3.27 | 2.45 | 4.22 | 4.42 | 6.53 | 10.08 |
| Dividend yield | 6.70% | 8.62% | 4.74% | 0.00% | 4.70% | 0.00% | 0.00% | 0.00% |
| Earnings per share | R$0.96 | R$0.93 | R$0.57 | R$0.65 | R$0.63 | R$0.42 | R$0.10 | -R$0.08 |
| Book value per share | R$13.21 | R$12.81 | R$12.43 | R$12.20 | R$11.92 | R$11.59 | R$8.11 | R$8.25 |
| ROE | 7.27% | 7.23% | 4.57% | 5.35% | 5.30% | 3.65% | 1.19% | -0.95% |
| ROIC | 13.13% | 13.35% | 11.73% | 12.20% | 7.08% | 7.25% | 2.34% | 1.24% |
| Gross margin | 15.29% | 15.00% | 14.92% | 14.66% | 14.15% | 13.93% | 15.37% | 15.94% |
| EBITDA margin | 4.80% | 4.62% | 4.73% | 4.88% | 4.00% | 4.06% | 3.96% | 2.08% |
| Net margin | 1.04% | 1.13% | 0.81% | 1.03% | 1.22% | 0.95% | 0.25% | -0.23% |
| Net debt/EBITDA | 1.87 | 1.22 | 1.43 | 1.26 | 1.44 | 1.03 | 2.32 | 4.59 |
PFRM3's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | R$11.5B | R$10.2B | R$8.7B | R$7.8B | R$6.4B | R$5.5B |
| Cost of revenue | -R$9.7B | -R$8.6B | -R$7.4B | -R$6.7B | -R$5.5B | -R$4.7B |
| Gross profit | R$1.8B | R$1.5B | R$1.3B | R$1.1B | R$907.6M | R$763.6M |
| EBITDA | R$550.1M | R$469.2M | R$409.7M | R$381.2M | R$256.6M | R$222.6M |
| EBIT | R$350M | R$299.7M | R$261.1M | R$242.9M | R$130.7M | R$120.6M |
| Financial result | -R$232.5M | -R$171.8M | -R$179.5M | -R$164M | -R$82M | -R$87.5M |
| Income before tax | R$117.5M | R$127.9M | R$81.6M | R$79M | R$48.7M | R$33.1M |
| Income tax | R$8.6M | -R$5M | -R$3.7M | R$6.1M | R$30.4M | R$28.6M |
| Net income | R$118.9M | R$114.6M | R$70.4M | R$80.9M | R$78.2M | R$52.3M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
PFRM3 against its sector
The same indicators for the company's other shares and the sector's largest stocks.
| Stock | P/E | P/B | Dividend yield (12m) | ROE | Market cap |
|---|---|---|---|---|---|
| PFRM3Profarma Distrib Prod Farmaceuticos | 5.93 | 0.64 | 8.71% | 10.71% | R$917.5M |
| BEEF3MINERVA S.A. | 8.60 | 2.50 | 4.97% | 29.04% | R$3.9B |
| RIAA3RIAA3 | 2.35 | 0.67 | 46.23% | 28.35% | R$3.6B |
| WLMM4WLM PART. E COMÉRCIO DE MÁQUINAS E VEÍCULOS S.A. | 7.37 | 0.71 | 12.38% | 9.63% | R$590.4M |
| WLMM3WLM PART. E COMÉRCIO DE MÁQUINAS E VEÍCULOS S.A. | 7.74 | 0.75 | 10.71% | 9.63% | R$590.4M |
| DMVF3D1000 VAREJO FARMA PARTICIPAÇÕES S.A. | 14.08 | 0.33 | 0.00% | 2.35% | R$306.1M |
Does PFRM3 pay dividends?
Dividend yield per year
- 0.00%2017
- 0.00%2018
- 0.00%2019
- 0.00%2020
- 4.70%2021
- 0.00%2022
- 4.74%2023
- 8.62%2024
- 6.70%2025
- 4.29%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 12/30/2025 | 01/15/2026 | R$0.32 |
| Dividend | 11/28/2025 | 12/23/2025 | R$0.16 |
| Dividend | 10/31/2025 | 11/25/2025 | R$0.16 |
| Interest on equity | 12/30/2024 | 01/15/2025 | R$0.29 |
| Interest on equity | 11/29/2024 | 12/12/2024 | R$0.14 |
| Interest on equity | 11/11/2024 | 11/26/2024 | R$0.14 |
| Interest on equity | 12/28/2023 | 01/10/2024 | R$0.27 |
| Interest on equity | 11/30/2023 | 12/12/2023 | R$0.12 |
| Interest on equity | 12/20/2022 | 01/13/2023 | R$0.17 |
| Interest on equity | 11/19/2021 | 12/01/2021 | R$0.27 |
| Dividend | 04/30/2014 | 05/14/2014 | R$0.13 |
| Dividend | 04/30/2014 | 05/13/2014 | R$0.14 |
See all 19 distributions
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 04/29/2013 | 05/10/2013 | R$0.20 |
| Dividend | 04/29/2011 | 05/12/2011 | R$0.13 |
| Dividend | 04/30/2010 | 05/12/2010 | R$0.26 |
| Dividend | 04/13/2009 | 04/27/2009 | R$0.11 |
| Dividend | 04/03/2008 | 04/14/2008 | R$0.08 |
| Interest on equity | 12/28/2007 | 04/14/2008 | R$0.14 |
| Dividend | 04/23/2012 | — | R$0.14 |
About Profarma Distrib Prod Farmaceuticos
- Sector
- Consumo Não Cíclico
- Segment
- Medicamentos e Outros Produtos
- Listing segment
- Novo Mercado
- Tag along
- 100.00%
- Free float
- 32.50%
- Shares issued
- 123.81M common
- Average daily trading
- R$882.2K
- Listed since
- 10/26/2006
- CNPJ
- 45.453.214/0001-51
Grupo Profarma é uma empresa brasileira especializada em distribuição e varejo no segmento farmacêutico, com mais de 60 anos de atuação no mercado. A companhia opera uma plataforma integrada de distribuição e varejo, contando com 15 centros de distribuição estrategicamente posicionados e quatro bandeiras de farmácias (Rede d1000, Drogasmil, Farmalife e Tamoio). A Profarma Distribuição é referência nacional em logística farmacêutica, conectando indústrias a mais de 49 mil pontos de venda com eficiência e segurança, cobrindo 17 estados brasileiros. A empresa entrega medicamentos, produtos de higiene e beleza com excelência, operando com frota própria e terceirizada, além de plataforma digital que facilita gestão de pedidos e abastecimento do canal farmacêutico.
Investor website| Shareholder | Common | Preferred | Total |
|---|---|---|---|
| BPL Brazil Holding Company | 38.18% | 0.00% | 38.18% |
| BMK Participações S.A.Controlling | 25.57% | 0.00% | 25.57% |
| LIS Capital Gestora Ltda | 9.13% | 0.00% | 9.13% |
| MANOEL BIRMARCKER | 1.18% | 0.00% | 1.18% |
| SAMMY BIRMARCKER | 1.11% | 0.00% | 1.11% |
| CACILDA DELEGAVE BIRMARCKER | 0.08% | 0.00% | 0.08% |
| DEBORAH UDERMAN | 0.06% | 0.00% | 0.06% |
| Outros | 23.73% | 0.00% | 23.73% |
| Ações Tesouraria | 0.97% | 0.00% | 0.97% |
Questions about PFRM3
How much is PFRM3 today?
PFRM3 is at R$7.40 (-0.54% on the day), last traded on 10/01/2026.
How much did PFRM3 pay in dividends in 2025?
PFRM3 paid R$0.61 per share in 2025, a dividend yield of 6.70%.
What are the P/E and P/B of PFRM3?
PFRM3 trades at a P/E of 5.93 and a P/B of 0.64.
How much did PFRM3 return in 12 months?
PFRM3 returned -2.84% in 12 months, with annualized volatility of 24.43% and a largest drawdown of -25.93%.
What sector is PFRM3 in?
Profarma Distrib Prod Farmaceuticos is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.